Han Xu, Zhu Ping, Liu Ni, et al. Narciclasine-Activated AKT/mTOR Pathway in Alleviating Hyperoxia-Induced Acute Lung Injury in Neonatal Rats. [J]. 28(7):1-6(2022)
DOI:
Han Xu, Zhu Ping, Liu Ni, et al. Narciclasine-Activated AKT/mTOR Pathway in Alleviating Hyperoxia-Induced Acute Lung Injury in Neonatal Rats. [J]. 28(7):1-6(2022) DOI: 10.13407/j.cnki.jpp.1672-108X.2022.07.001.
Narciclasine-Activated AKT/mTOR Pathway in Alleviating Hyperoxia-Induced Acute Lung Injury in Neonatal Rats
Objective: To explore the effects and mechanism of narciclasine on hyperoxia-induced acute lung injury in neonatal rats. Methods: A total of 40 full-term neonatal Wistar rats were randomly divided into the normoxia group (21% O2)
normoxia+narciclasine group
hyperoxia group (85% O2
hyperoxia) and hyperoxia+narciclasine group
with 10 cases in each group. Rats in all groups were exposed under conditions of different oxygen contents for 7 d. Other 50 full-term neonatal rats were randomly divided into the normoxia group
hyperoxia group
hyperxia+narciclasine group
hyperoxia+narciclasine+protein kinase B (AKT) inhibitor group and hyperoxia+narciclasine+rapamycin group
with 10 cases in each group. All drug therapy groups were intraperitoneally injected with 1 mg/kg narciclasine
1 mg/kg AKT inhibitor and 4 mg/kg rapamycin at 0
2
4 and 6 d after birth
respectively. The levels of lung injury
pro-inflammatory cytokines
fibrosis and lung tissue apoptosis among all groups were compared. Results: Compared with the normoxia group
body mass and levels of B-cell lymphoma-2 (Bcl-2)/Bcl-2 associated X protein (Bax) in lung tissues decreased significantly in the hyperoxia group
total number of cells in bronchoalveolar lavage fluid (BALF)
total protein
wet and dry weight of lung tissues
levels of tumor necrosis factor α (TNF-α)
interleukin-1β (IL-1β)
monocyte chemotactic protein 1 (MCP-1) and IL-6 in BALF and serum
expressions of α smooth actin (α-SMA)
vimentin and collagen Ⅰ in lung tissues
apoptosis rate of lung tissues
fibroblast apoptosis rate of primary lung
phosphorylated protein kinase B (p-AKT)/AKT and phosphorylated mammalian target of rapamycin (p-mTOR)/mTOR increased significantly (P<0.05)
and there was no significant change in the above indicators between the normoxia group and the normoxia+narciclasine group (P>0.05). Compared with the hyperoxia group
body mass and Bcl-2/Bax levels in lung tissues increased significantly in the hyperoxia+narciclasine group
total number of cells in BALF
total protein
wet and dry weight of lung tissues
levels of TNF-α
IL-1β
MCP-1 and IL-6 in BALF and serum
expressions of α-SMA
vimentin and collagen Ⅰ in lung tissues
apoptosis rate of lung tissues
fibroblast apoptosis rate of primary lung
p-AKT/AKT and p-mTOR/mTOR decreased significantly (P<0.05). Compared with the hyperoxia+narciclasine group
levels of TNF-α and IL-1β increased significantly in the hyperoxia+narciclasine+AKT inhibitor group (P<0.05)
levels of TNF-α
IL-1β and expressions of collagen Ⅰ increased significantly in the hyperoxia+narciclasine+rapamycin group
and the levels of Bcl-2/Bax decreased significantly (P<0.05). Conclusion: Narciclasine can protect neonatal rats from hyperoxia-induced lung injury. The mechanism may be related to that narciclasine can activate AKT/mTOR signaling pathways
improve the inflammation response
relieve the lung fibrosis and inhibit the apoptosis of lung tissues.
Relief of ODN2088 for Acute Lung Injury in Rats with Sepsis Induced by Mitochondrial DNA
Related Author
Tang Tian
Li Shaojun
Guo Pengfei
Yang Lin
Ao Xiaoxiao
Hu Lan
Tan Liping
Related Institution
Children’s Hospital of Chongqing Medical University, Ministry of Education Key Laboratory of Child Development and Disorders, National Clinical Research Center for Child Health and Disorders, China International Science and Technology Cooperation Base of Child Development and Critical Disorders, Chongqing Key Laboratory of Pediatrics